Vyome Holdings (HIND) Receivables (2017 - 2026)
Vyome Holdings (HIND) posted quarterly Receivables of $579644.0 for Q1 2026, down 21.03% year-over-year from $734000.0 in Q1 2025, and up 487.81% quarter-over-quarter from $98611.0 in Q4 2025.
Vyome Holdings (HIND) Receivables (2017 - 2026) Analysis & Trends
Vyome Holdings' Receivables history runs 10 years deep, the most recent figure standing at $579644.0 for Q1 2026.
- In Q1 2026, Receivables fell 21.03% year-over-year to $579644.0; the TTM figure through Mar 2026 stood at $579644.0 (down 21.03% YoY), while the FY2025 annual figure was $601862.0, down 7.27% from the prior year.
- Receivables for Q1 2026 stood at $579644.0, up from $98611.0 in the prior quarter.
- The five-year high for Receivables was $2.4 million in Q2 2022, with the low at $98611.0 in Q4 2025.
- The 5-year median for Receivables is $1.6 million (2024), against an average of $1.5 million.
- Peak annual rise in Receivables reached 0.0% in 2025, while the deepest fall reached 84.81% in 2025.
- Vyome Holdings' Receivables stood at $2.2 million in 2022, then dropped by 23.9% to $1.7 million in 2023, then tumbled by 60.88% to $649052.0 in 2024, then sank by 84.81% to $98611.0 in 2025, then surged by 487.81% to $579644.0 in 2026.
- Business Quant data shows HIND's Receivables at $579644.0 in Q1 2026, $98611.0 in Q4 2025, and $629915.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | 593,757.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 593,757.00 |
| Mar 31, 2026 | 579,644.00 |
| Dec 31, 2025 | 98,611.00 |
| Sep 30, 2025 | 629,915.00 |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 734,000.00 |
| Dec 31, 2024 | 649,052.00 |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 1.66 Mn |
| Sep 30, 2023 | 2.20 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 2.13 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Sep 30, 2022 | 2.23 Mn |
| Jun 30, 2022 | 2.45 Mn |
| Mar 31, 2022 | 2.41 Mn |
| Dec 31, 2021 | 2.82 Mn |
| Sep 30, 2021 | 3.46 Mn |